Regeneron Pharmaceuticals, Inc.

E. Ohman J:or Asset Management AB REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/12/2026

Shares

2,840

Value ($000)

2,192

Weight

0.1%

2012 Q2 - 2025 Q4 (54 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/12/2026	2,192	0.1%	2,840	12/31/2025
2025 Q3	10/17/2025	2,429	0.1%	4,320	9/30/2025
2025 Q2	7/8/2025	2,268	0.1%	4,320	6/30/2025
2025 Q1	4/11/2025	2,981	0.1%	4,700	3/31/2025
2024 Q4	1/27/2025	3,540	0.1%	4,970	12/31/2024
2024 Q3	10/23/2024	4,657	0.1%	4,430	9/30/2024
2024 Q2	8/13/2024	4,950	0.1%	4,710	6/30/2024
2024 Q1	5/14/2024	4,341	0.1%	4,510	3/31/2024
2023 Q4	2/15/2024	3,689	0.1%	4,200	12/31/2023
2023 Q2	4/5/2024	6,703	0.2%	9,329	6/30/2023
2023 Q1	4/5/2024	7,090	0.3%	8,629	3/31/2023
2022 Q4	4/5/2024	5,576	0.2%	7,729	12/31/2022
2022 Q3	4/5/2024	8,734	0.4%	12,679	9/30/2022
2022 Q2	4/5/2024	9,980	0.4%	16,883	6/30/2022
2022 Q1	4/5/2024	13,258	0.4%	18,983	3/31/2022
2021 Q4	4/5/2024	3,221	0.1%	5,100	12/31/2021
2021 Q3	4/5/2024	2,844	0.1%	4,700	9/30/2021
2021 Q2	4/5/2024	2,513	0.1%	4,500	6/30/2021
2021 Q1	4/5/2024	1,940	0.1%	4,100	3/31/2021
2020 Q4	4/5/2024	2,029	0.1%	4,200	12/31/2020
2020 Q3	4/5/2024	2,351	0.1%	4,200	9/30/2020
2020 Q2	4/5/2024	2,370	0.1%	3,800	6/30/2020
2020 Q1	4/5/2024	1,465	0.1%	3,000	3/31/2020
2019 Q4	4/5/2024	1,427	0.1%	3,800	12/31/2019
2019 Q3	4/5/2024	971	0.1%	3,500	9/30/2019
2019 Q2	4/5/2024	14,139	0.9%	45,174	6/30/2019
2019 Q1	4/5/2024	20,434	1.4%	49,764	3/31/2019
2018 Q4	4/5/2024	15,689	1.1%	42,005	12/31/2018
2018 Q3	4/5/2024	9,987	0.6%	24,718	9/30/2018
2018 Q2	4/5/2024	7,928	0.6%	22,981	6/30/2018
2018 Q1	4/5/2024	758	0.1%	2,200	3/31/2018
2017 Q4	4/5/2024	940	0.1%	2,500	12/31/2017
2017 Q3	4/5/2024	939	0.1%	2,100	9/30/2017
2017 Q2	4/5/2024	1,031	0.1%	2,100	6/30/2017
2017 Q1	4/5/2024	814	0.1%	2,100	3/31/2017
2016 Q4	4/5/2024	624	0.1%	1,700	12/31/2016
2016 Q3	4/5/2024	683	0.1%	1,700	9/30/2016
2016 Q2	4/5/2024	524	0.1%	1,500	6/30/2016
2016 Q1	4/5/2024	541	0.1%	1,500	3/31/2016
2015 Q4	4/5/2024	814	0.1%	1,500	12/31/2015
2015 Q3	4/5/2024	605	0.2%	1,300	9/30/2015
2015 Q2	4/5/2024	816	0.2%	1,600	6/30/2015
2015 Q1	4/5/2024	722	0.2%	1,600	3/31/2015
2014 Q4	4/5/2024	653	0.2%	1,600	12/31/2014
2014 Q3	4/5/2024	577	0.1%	1,600	9/30/2014
2014 Q2	4/5/2024	452	0.1%	1,600	6/30/2014
2014 Q1	4/5/2024	601	0.1%	2,000	3/31/2014
2013 Q4	4/5/2024	556	0.1%	2,000	12/31/2013
2013 Q3	4/5/2024	626	0.2%	2,000	9/30/2013
2013 Q2	4/5/2024	360	0.1%	1,600	6/30/2013
2013 Q1	4/5/2024	370	0.1%	2,100	3/31/2013
2012 Q4	4/5/2024	359	0.1%	2,100	12/31/2012
2012 Q3	4/5/2024	229	0.1%	1,500	9/30/2012
2012 Q2	4/5/2024	171	0.1%	1,500	6/30/2012